Table 1.
Clinical characteristics
| Reference Range | ESRD Group (n=33) | Control group (n=21) | p | |
|---|---|---|---|---|
| General | ||||
| Age | 60.7 ± 1.1 | 56.7 ± 1.3 | ns | |
| Gender (M/F) | 31/2 | 19/2 | ns | |
| Race (Cauc/AA/As) | 22/11/0 | 19/0/2 | ||
| Ethnicity (MA/NHW/AA/As) | 20/2/11/0 | 12/7/0/2 | ||
| Body Mass Index | 27.8 ± 0.8 | 28.9 ± 0.9 | ns | |
| Dialysis Adequacy | ||||
| Kt/V a | 1.4 | 1.82 ± 0.34 | NA | |
| Nutrition | ||||
| Normalized PCR a | 1.0 – 1.4 | 0.97 ± 0.26 | NA | |
| Albumin (g/dL) a | 3.6 – 4.8 | 3.54 ± 0.39 | 4.2 ± 0.11 | <.05 |
| Inflammation | ||||
| CRP (mg/dL) b | 0 – 0.3 | 0.41 (0.18 – 1.04) | 0.2 (0.08 – 0.63) | <.05 |
| WBC (103/μl) a | 4.3 – 10.8 | 6.97 ± 1.94 | 7.22± 0.84 | ns |
| Neutrophils (103/μl) a | 2.2 – 7.6 | 4.68 ± 1.79 | 3.81 ± 0.47 | ns |
Cauc, Caucasian; AA, African American; As, Asian; MA, Mexican American; NH, Non-Hispanic. NA, not applicable
a
Variables presented as mean ± SD;
b
Variables presented as median (25th–75th percentile);
c
from centralized laboratory reference range;
d
from general population reference range [ref];
e
from K/DOQI Guidelines [ref].